GO:0070461 | SAGA-type complex | 3.46e-06 | 4.99e-02 | 9.324 | 2 | 2 | 5 |
GO:0006355 | regulation of transcription, DNA-templated | 7.53e-06 | 1.09e-01 | 3.270 | 6 | 43 | 997 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 1.90e-05 | 2.74e-01 | 8.187 | 2 | 4 | 11 |
GO:0006366 | transcription from RNA polymerase II promoter | 7.88e-05 | 1.00e+00 | 3.935 | 4 | 30 | 419 |
GO:0000398 | mRNA splicing, via spliceosome | 1.15e-04 | 1.00e+00 | 4.874 | 3 | 15 | 164 |
GO:0044822 | poly(A) RNA binding | 2.05e-04 | 1.00e+00 | 2.924 | 5 | 50 | 1056 |
GO:0005654 | nucleoplasm | 2.30e-04 | 1.00e+00 | 2.889 | 5 | 64 | 1082 |
GO:0003713 | transcription coactivator activity | 3.42e-04 | 1.00e+00 | 4.342 | 3 | 24 | 237 |
GO:0006396 | RNA processing | 5.81e-04 | 1.00e+00 | 5.764 | 2 | 5 | 59 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0071013 | catalytic step 2 spliceosome | 1.01e-03 | 1.00e+00 | 5.361 | 2 | 7 | 78 |
GO:0019046 | release from viral latency | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 2 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0060242 | contact inhibition | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0060913 | cardiac cell fate determination | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0006325 | chromatin organization | 2.30e-03 | 1.00e+00 | 4.764 | 2 | 12 | 118 |
GO:0001714 | endodermal cell fate specification | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 2 | 5 |
GO:0070937 | CRD-mediated mRNA stability complex | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 3 | 6 |
GO:0003677 | DNA binding | 4.51e-03 | 1.00e+00 | 2.396 | 4 | 49 | 1218 |
GO:0044212 | transcription regulatory region DNA binding | 4.60e-03 | 1.00e+00 | 4.254 | 2 | 17 | 168 |
GO:0070688 | MLL5-L complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0043254 | regulation of protein complex assembly | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0005515 | protein binding | 5.23e-03 | 1.00e+00 | 1.090 | 8 | 198 | 6024 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 5 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 5 | 9 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 5 | 9 |
GO:0048188 | Set1C/COMPASS complex | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 4 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 2 | 10 |
GO:0010467 | gene expression | 6.76e-03 | 1.00e+00 | 2.845 | 3 | 45 | 669 |
GO:0035198 | miRNA binding | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 12 |
GO:0008143 | poly(A) binding | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 2 | 12 |
GO:0071480 | cellular response to gamma radiation | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 2 | 13 |
GO:0030914 | STAGA complex | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 3 | 13 |
GO:0008380 | RNA splicing | 8.32e-03 | 1.00e+00 | 3.813 | 2 | 22 | 228 |
GO:0031011 | Ino80 complex | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 6 | 14 |
GO:0043981 | histone H4-K5 acetylation | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 5 | 15 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 3 | 15 |
GO:0001824 | blastocyst development | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 2 | 15 |
GO:0043982 | histone H4-K8 acetylation | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 5 | 15 |
GO:0043274 | phospholipase binding | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 16 |
GO:0000166 | nucleotide binding | 1.06e-02 | 1.00e+00 | 3.629 | 2 | 13 | 259 |
GO:0043984 | histone H4-K16 acetylation | 1.18e-02 | 1.00e+00 | 6.398 | 1 | 5 | 19 |
GO:0000123 | histone acetyltransferase complex | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 6 | 21 |
GO:0005730 | nucleolus | 1.31e-02 | 1.00e+00 | 1.966 | 4 | 66 | 1641 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 2 | 22 |
GO:0045787 | positive regulation of cell cycle | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 4 | 22 |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 3 | 25 |
GO:0035329 | hippo signaling | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 5 | 26 |
GO:0003682 | chromatin binding | 1.66e-02 | 1.00e+00 | 3.293 | 2 | 19 | 327 |
GO:0071339 | MLL1 complex | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 6 | 27 |
GO:0003723 | RNA binding | 1.81e-02 | 1.00e+00 | 3.228 | 2 | 18 | 342 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 32 |
GO:0035019 | somatic stem cell maintenance | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 6 | 40 |
GO:0031124 | mRNA 3'-end processing | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 2 | 42 |
GO:0015030 | Cajal body | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 44 |
GO:0006369 | termination of RNA polymerase II transcription | 2.77e-02 | 1.00e+00 | 5.154 | 1 | 2 | 45 |
GO:0009611 | response to wounding | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 5 | 52 |
GO:0005634 | nucleus | 3.27e-02 | 1.00e+00 | 1.077 | 6 | 159 | 4559 |
GO:0006406 | mRNA export from nucleus | 3.74e-02 | 1.00e+00 | 4.715 | 1 | 4 | 61 |
GO:0006310 | DNA recombination | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 7 | 65 |
GO:0010468 | regulation of gene expression | 4.17e-02 | 1.00e+00 | 4.559 | 1 | 2 | 68 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 4 | 74 |
GO:0002020 | protease binding | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 6 | 74 |
GO:0007517 | muscle organ development | 5.06e-02 | 1.00e+00 | 4.271 | 1 | 4 | 83 |
GO:0009653 | anatomical structure morphogenesis | 5.06e-02 | 1.00e+00 | 4.271 | 1 | 2 | 83 |
GO:0050821 | protein stabilization | 5.36e-02 | 1.00e+00 | 4.187 | 1 | 3 | 88 |
GO:0001649 | osteoblast differentiation | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 5 | 92 |
GO:0006364 | rRNA processing | 5.72e-02 | 1.00e+00 | 4.092 | 1 | 3 | 94 |
GO:0005737 | cytoplasm | 5.81e-02 | 1.00e+00 | 1.089 | 5 | 124 | 3767 |
GO:0030018 | Z disc | 5.89e-02 | 1.00e+00 | 4.046 | 1 | 4 | 97 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 6.73e-02 | 1.00e+00 | 2.197 | 2 | 39 | 699 |
GO:0030529 | ribonucleoprotein complex | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 5 | 112 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 8.33e-02 | 1.00e+00 | 2.022 | 2 | 41 | 789 |
GO:0010628 | positive regulation of gene expression | 8.75e-02 | 1.00e+00 | 3.456 | 1 | 7 | 146 |
GO:0006974 | cellular response to DNA damage stimulus | 9.04e-02 | 1.00e+00 | 3.408 | 1 | 7 | 151 |
GO:0016607 | nuclear speck | 1.02e-01 | 1.00e+00 | 3.220 | 1 | 12 | 172 |
GO:0005667 | transcription factor complex | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 17 | 175 |
GO:0007049 | cell cycle | 1.04e-01 | 1.00e+00 | 3.203 | 1 | 6 | 174 |
GO:0031625 | ubiquitin protein ligase binding | 1.06e-01 | 1.00e+00 | 3.170 | 1 | 5 | 178 |
GO:0003714 | transcription corepressor activity | 1.06e-01 | 1.00e+00 | 3.170 | 1 | 11 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 22 | 184 |
GO:0008134 | transcription factor binding | 1.41e-01 | 1.00e+00 | 2.727 | 1 | 18 | 242 |
GO:0043025 | neuronal cell body | 1.43e-01 | 1.00e+00 | 2.710 | 1 | 9 | 245 |
GO:0006281 | DNA repair | 1.52e-01 | 1.00e+00 | 2.618 | 1 | 14 | 261 |
GO:0003779 | actin binding | 1.54e-01 | 1.00e+00 | 2.591 | 1 | 10 | 266 |
GO:0006954 | inflammatory response | 1.60e-01 | 1.00e+00 | 2.532 | 1 | 6 | 277 |
GO:0008283 | cell proliferation | 1.87e-01 | 1.00e+00 | 2.289 | 1 | 14 | 328 |
GO:0043565 | sequence-specific DNA binding | 1.96e-01 | 1.00e+00 | 2.212 | 1 | 11 | 346 |
GO:0009986 | cell surface | 2.25e-01 | 1.00e+00 | 1.995 | 1 | 9 | 402 |
GO:0006351 | transcription, DNA-templated | 2.26e-01 | 1.00e+00 | 1.148 | 2 | 57 | 1446 |
GO:0042802 | identical protein binding | 2.65e-01 | 1.00e+00 | 1.727 | 1 | 19 | 484 |
GO:0016020 | membrane | 2.83e-01 | 1.00e+00 | 0.931 | 2 | 46 | 1681 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.04e-01 | 1.00e+00 | 1.491 | 1 | 37 | 570 |
GO:0008270 | zinc ion binding | 4.75e-01 | 1.00e+00 | 0.685 | 1 | 27 | 997 |
GO:0005739 | mitochondrion | 4.76e-01 | 1.00e+00 | 0.683 | 1 | 23 | 998 |
GO:0005829 | cytosol | 4.79e-01 | 1.00e+00 | 0.361 | 2 | 86 | 2496 |
GO:0005524 | ATP binding | 5.72e-01 | 1.00e+00 | 0.304 | 1 | 31 | 1298 |